单味中药对多重耐药鲍曼不动杆菌 体外抑菌作用的研究

目的研究鱼腥草等10种广谱抗菌中药对多重耐药鲍曼不动杆菌的抑菌作用,为临床治疗多重耐药鲍曼不动杆菌的感染提供新的治疗思路和途径。方法采用药敏纸片琼脂扩散法和微量肉汤稀释法测定板蓝根、鱼腥草、黄芩、黄连、五倍子、金银花、苦参、连翘、乌梅和穿心莲等10种单味中药的抑菌效果和最低抑菌浓度(MIC)。结果五倍子对多重耐药鲍曼不动杆菌抑菌作用最强,抑菌圈直径为17~30mm,MIC值为0.975mg/mL;黄芩也有较好的抑菌效果,MIC值为15.63mg/mL;乌梅抑菌作用相对较弱;而黄连、鱼腥草、连翘、板蓝根、苦参、金银花和穿心莲的抑菌活性很弱甚至无抑菌效果。结论 10种单味中药中五倍子对多重耐药鲍曼不动杆菌的抑菌效果最强,为临床用药提供有效指导。     

替加环素与多粘菌素B对泛耐药鲍曼不动杆菌体外研究

目的为治愈耐舒普深的泛耐药鲍曼不动杆菌（PDR-Ab）提供新药。方法替加环素采用二倍琼脂稀释法,多粘菌素B用E-test条法测分离目标菌株100株的最低抑菌浓度（M IC）,并用WHONET 5.4软件分析数据。结果多粘菌素B对耐舒普深的泛耐药鲍曼不动杆菌株的M IC值分布情况为：1.5 mg/L为2株,1.0 mg/L为9株,0.75 mg/L为9株,0.5 mg/L为38株,0.38 mg/L为34株,0.25 mg/L为8株,均为敏感;替加环素对耐舒普深的泛耐药鲍曼不动杆菌株的M IC值分布情况为：≥32 mg/L为0株、16 mg/L为2株、8 mg/L为3株、4 mg/L为4株、2 mg/L为6株、1 mg/L为9株、0.5 mg/L为30株、0.25 mg/L为33株、0.125 mg/L为9株、0.06 mg/L为2株、0.03 mg/L为2株,敏感率为95.0%,中敏率为3.0%,耐药率为2.0%。结论替加环素或多粘菌素B是目前对耐舒普深的泛耐药鲍曼不动杆菌最有效药物之一。     

黄酮化合物对耐药性鲍曼不动杆菌抑菌作用研究

为探索中药黄酮化合物对耐药性鲍曼不动杆菌的抑菌效果。研究通过微量肉汤稀释法,考察40种中药及天然来源的黄酮化合物对三株耐药性鲍曼不动杆菌菌株的体外抑菌作用,测试其最低抑菌浓度与最低杀菌浓度;采用结晶紫染色法进一步测定目标化合物对鲍曼不动杆菌生物被膜形成的能力;探索黄酮联合头孢哌酮/舒巴坦对鲍曼不动杆菌的抑菌效果。研究表明,黄酮单体对于鲍曼不动杆菌具有不同程度的体外抑菌作用。其中部分具有轻微作用,其最小抑菌浓度仅为0.5 mg/mL;黄芩素和汉黄芩苷具有显著的抑菌作用,其最小抑菌浓度分别为0.062 5和0.125 mg/mL;同时,黄芩素对鲍曼不动杆菌生物被膜形成具有明显的抑制作用。此外,黄芩素和头孢哌酮/舒巴坦联合作用于耐药鲍曼不动杆菌与单用黄芩素或头孢哌酮/舒巴坦比较,浓度有所降低。综上,黄芩素对耐药性鲍曼不动杆菌有较好的体外抑菌效果,这为治疗耐药性鲍曼不动杆菌引发的感染的治疗提供新思路和方向。     

茶叶水提物对猪源耐药大肠杆菌的抑制作用

本研究旨在考察茶叶水提物对耐药大肠杆菌的抑制作用,为大肠杆菌病的防治提供依据。采用体外抑菌试验测定红茶水提物和绿茶水提物对猪源耐药大肠杆菌分离株的抑制活性,然后观察具有较强抑菌活性的绿茶水提物对大肠杆菌攻毒小鼠的保护作用。结果表明,随着浓度的增加,两种茶叶水提物的抑菌活性增强;红茶水提物和绿茶水提物对13株大肠杆菌分离株的MIC值分别为62.5~250.0 mg/m L、62.5~125.0 mg/m L,提示绿茶水提物的抑菌活性较强;两种茶叶水提物对13个大肠杆菌分离株的抑制活性强弱表现出一定的差异。攻毒后48 h,攻毒组小鼠全部死亡,绿茶水提物组小鼠的存活率为20%;绿茶水提物组小鼠的十二指肠和空肠肠绒毛高度与对照组比较差异不显著,而显著大于攻毒组(P0.05),提示绿茶水提物对大肠杆菌攻毒小鼠的肠道损伤具有一定缓解作用。上述结果提示,绿茶水提物对大肠杆菌具有很好的抑制作用,可作为防治大肠杆菌病的备选生物活性物质之一。     

BALB/c小鼠多重耐药鲍曼不动杆菌肺部感染模型的建立和评估

本研究旨在构建小鼠多重耐药鲍曼不动杆菌肺部感染模型，评估模型小鼠各项炎性指标的变化特征，为研究多重耐药鲍曼不动杆菌的体内致病性提供参考。首先采用聚合酶链反应(polymerase chain reaction，PCR)检测拟建模用鲍曼不动杆菌的毒力基因分布特征，然后通过感染秀丽隐杆线虫筛选建模菌株。结果显示，A5株携带更多的毒力基因，致病性也更强，被选为建模菌株。给小鼠注射环磷酰胺建立免疫抑制，雾化吸入A5株菌液(高、低密度组)，监测小鼠状态、肺组织改变、肺组织和肺泡灌洗液(bronchoalveolar lavage fluid，BALF)中菌落计数、外周血白细胞和中性粒细胞计数、细胞因子等的变化。结果显示，感染A5株的小鼠较对照组状态更差，肺充血水肿，肺组织和BALF中出现鲍曼不动杆菌增殖。与低密度组相比，高密度组小鼠外周血白细胞和中性粒细胞增加更明显(白细胞F＝78.630，P＝0.000；中性粒细胞：F＝4.762，P＝0.053)。与对照组相比，感染A5株的小鼠血清白细胞介素6(interleukin 6，IL-6)水平升高并趋于稳定(F＝14.382, P＝0.001)，而肿瘤坏死因子α(tumor necrosis factor α，TNF-α)水平持续升高(F＝4.558，P＝0.032)，高密度组与低密度组TNF-α变化趋势不完全一致。结果提示，本研究成功构建了小鼠多重耐药鲍曼不动杆菌肺部感染模型，且模型小鼠出现了明显的感染症状，接种菌量与小鼠感染程度呈正相关。     

头孢他啶联合阿米卡星对多重耐药的鲍曼不动杆菌的体外抗菌作用分析

目的了解头孢他啶与阿米卡星联合对鲍曼不动杆菌体外药敏试验效果,探索多药耐药的临床用药新途径。方法采用微量肉汤稀释法、棋盘法分别测定头孢他啶、阿米卡星两药单独及两种不同浓度药物组合时对临床分离的24株多重耐药的鲍曼不动杆菌最低抑菌浓度(MIC),计算部分抑菌浓度(FIC)指数,应用FIC指数来计算及判读两种抗菌药物联用对多重耐药的鲍曼不动杆菌体外抗菌作用的效果。结果头孢他啶与阿米卡星联合应用,能显著降低各自的MIC值,分别有75%的菌株表现为协同作用,20.8%的菌株表现为相加作用,有4.2%发生无关作用,没有拮抗作用发生。结论对多重耐药的鲍曼不动杆菌的感染,可使用头孢他啶与阿米卡星进行联合治疗。     

竹叶提取物的体外抑菌及抗氧化活性的研究

本文用水提取竹叶有效成分,将提取液浓缩至含生药量约1.0 g/mL,经醇沉后取清液浓缩,再经石油醚、三氯甲烷、乙酸乙酯、正丁醇分步萃取,得不同极性的各部分提取物。以金黄色葡萄球菌和大肠杆菌为供试菌,采用抑菌圈法(琼脂扩散法)和最低抑菌浓度(MIC)法测定其抑菌效果。结果显示,石油醚、三氯甲烷、乙酸乙酯部分均表现抑菌活性。各供试样对两种菌的抑菌圈直径达9.8～18.4 mm,最低抑菌浓度分别为1.25 mg/mL2,.50 mg/mL和5.00 mg/mL。最后采用亚硝基红盐-Co2+褪色法研究了竹叶提取物对.OH的清除作用,结果表明三氯甲烷和乙酸乙酯部分萃取物的抗氧化性明显优于水提物,其中乙酸乙酯部分萃取物的IC50值为1.06 mg/mL。     

Antimicrobial activities of 26 Yunnan plants extracts against clinical multi-drug resistant pathogens in vitro

研究26种云南滇东南产植物80％乙醇提取物的体外抗耐药菌作用.制备植物的醇提物,用琼脂打孔法对其进行抗菌活性的筛选.通过微量稀释法测定提取物的最低抑菌浓度[minimum inhibitory concentration(MIC)]、最低杀细菌浓度[minimum bactericidal concentration(MBC)]及最低杀真菌浓度[minimum fungicidal concentration(MFC)].结果表明:26种提取物中有9种对金黄色葡萄球菌(简称金葡菌)、大肠埃希菌、铜绿假单胞菌、白色念珠菌有不同程度的抑制活性;其中以红花荷、马蹄参、百花贝母兰、二色大包兰和光序肉实树提取物对耐甲氧西林金葡菌的抑菌作用最强,其MIC/MBC(mg/L)范围分别为512/2048～＞2048,512/2048～＞2048,256-512/2048～＞2048,512～1024/1024～＞2048和512～1024/＞2048.另外,肋果茶提取物对铜绿假单胞菌及白色念珠菌有较好的抑制作用,其对铜绿假单胞菌及其耐药菌株的MIC/MBC为512～2048/＞2048mg/L;对白色念珠菌及其耐药菌株的MIC/MFC均为2048/＞2048 mg/L.26种植物提取物对大肠埃希菌的抑制作用均较弱.     

26种滇产植物提取物的体外抗耐药菌作用研究

研究26种云南滇东南产植物80%乙醇提取物的体外抗耐药菌作用。制备植物的醇提物,用琼脂打孔法对其进行抗菌活性的筛选。通过微量稀释法测定提取物的最低抑菌浓度[minimum inhibitory concentration(MIC)]、最低杀细菌浓度[minimum bactericidal concentration(MBC)]及最低杀真菌浓度[minimum fungicidal concentration(MFC)]。结果表明:26种提取物中有9种对金黄色葡萄球菌(简称金葡菌)、大肠埃希菌、铜绿假单胞菌、白色念珠菌有不同程度的抑制活性;其中以红花荷、马蹄参、百花贝母兰、二色大包兰和光序肉实树提取物对耐甲氧西林金葡菌的抑菌作用最强,其MIC/MBC(mg/L)范围分别为512/2048～>2048,512/2048～>2048,256-512/2048～>2048,512～1024/1024～>2048和512～1024/>2048。另外,肋果茶提取物对铜绿假单胞菌及白色念珠菌有较好的抑制作用,其对铜绿假单胞菌及其耐药菌株的MIC/MBC为512～2048/>2048mg/L;对白色念珠菌及其耐药菌株的MIC/MFC均为2048/>2048mg/L。26种植物提取物对大肠埃希菌的抑制作用均较弱。     

红葱不同极性提取物抑菌活性研究

选用3种常见的食源性菌金黄色葡萄球菌ATCC25923、大肠杆菌ATCC25922、鼠伤寒沙门氏菌ATCC14028作为供试菌种,采用试管二倍稀释法定量测定红葱乙醇粗提液(1 g/L)的最低抑菌浓度(MIC)和最低杀菌浓度(MBC),并用打孔法分别测定红葱石油醚、乙酸乙酯、氯仿、正丁醇和乙醇不同极性提取物的抑菌圈大小。结果表明:乙醇粗提液对金黄色葡萄球菌的MIC和MBC值分别为3. 91 mg/mL,与7. 81 mg/mL,红葱不同极性提取物对3种细菌均有不同程度的抑制作用,对金黄色葡萄球菌高度敏感。石油醚提取部位活性最强,其对金黄色葡萄球菌的最大抑菌直径达31. 83±0. 50 mm。实验结果为红葱提取物进一步在食品天然防腐剂的开发应用提供参考依据。     

紫穗槐种子提取物的抑菌活性研究

目的研究紫穗槐种子提取物的抑菌活性。方法将紫穗槐种子乙醇提取物分别通过石油醚、乙酸乙酯和正丁醇萃取,选择金黄色葡萄球菌和肺炎克雷伯杆菌为供试菌,采用试管二倍稀释法测定紫穗槐种子提取物的最小抑菌浓度（MIC）和最小杀菌浓度（MBC）,涂布平板法绘制杀菌曲线,电镜下观察药物对细菌超微结构的影响。结果紫穗槐种子提取物经乙酸乙酯萃取后对供试菌抑制作用较强,其中对金黄色葡萄球菌的MIC和MBC分别为2．5、5．0mg／mL;对肺炎克雷伯杆菌的MIC和MBC分别为5．0、10．0mg／mL;杀菌曲线结果表明,药物对供试菌的抑制作用存在浓度和时间依赖性;电镜结果说明,药物的作用可能与破坏菌体细胞壁、改变细胞膜通透性有关。结论紫穗槐种子提取物具有显著的抗菌活性。     

诃子不同炮制品抗氧化、抗菌作用的实验研究

目的:对比研究诃子不同炮制品的抗氧化、抗菌作用。方法:小鼠D-半乳糖注射致衰老,同时给予诃子、沙炒诃子、清炒诃子、麦麸煨诃子4w,采血检测小鼠鼠血清T-AOC、SOD含量;小鼠体内感染金黄色葡萄球菌,同时给予诃子、沙炒诃子、清炒诃子、麦麸煨诃子7d,观察小鼠死亡保护率。结果:诃子不同炮制品均能升高D-半乳糖衰老小鼠血清T-AOC、SOD含量,一定程度上提高小鼠死亡保护率,结论:诃子不同炮制品有一定抗氧化、抗菌作用。     

Preparation and antimicrobial activity of scleraldehyde from Schizophyllum commune

The present study investigates the antimicrobial activity of oxidized schizophyllan (scleraldehyde) against Gram-positive and Gram-negative bacteria by diffusion and tube dilution analysis. Schizophyllan is a natural polysaccharide produced by fungi of the genus Schizophyllum. Periodate oxidation specifically cleaves the vicinal glycols in scleraldehyde to form their dialdehyde derivatives. The antibacterial activity exhibited by scleraldehyde was defined using various tests such as the disc diffusion assay, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). MIC and MBC values were found to be in the range of 3.0-8.0 mg/mL. Hence, the present studies establish that the scleraldehyde possesses effective antibacterial properties and can be used as a biopreservative for preservation of raw hides and skins.     

甘草提取物对四种牙周常见致病菌的抑菌作用

目的体外评价甘草提取物对牙龈卟啉单胞菌、中间普氏菌、具核梭杆菌和伴放线放线杆菌四种牙周常见致病菌的抑制效果。方法以牙龈卟啉单胞菌、中间普氏菌、具核梭杆菌和伴放线放线杆菌四种牙周常见致病菌作为供试菌,采用液体稀释法,考察甘草提取物对这四种细菌的最小抑菌浓度(MIC)和最小杀菌浓度(MBC);并采用不同浓度的甘草提取物溶液,绘制甘草提取物对四种牙周致病菌的时间-杀菌曲线。结果甘草提取物对牙龈卟啉单胞菌、中间普氏菌、具核梭杆菌和伴放线放线杆菌的MIC值分别为1.50、1.50、0.75和1.50mg/mL,MBC值分别为6、3、3和3mg/mL。当甘草提取物达到对四种细菌的MBC值时,对于牙龈卟啉单胞菌、中间普氏菌、伴放线放线杆菌可在2h后可达到杀菌效果,对于具核梭杆菌可在4h后达到杀菌效果。结论甘草提取物对以上四种牙周常见致病菌具有良好的抑菌及杀菌作用。     

Inhibition of Helicobacter pylori by garlic extract (Allium sativum)

Abstract The antibacterial effect of aqueous garlic extract (AGE) was investigated against Helicobacter pylori . Sixteen clinical isolates and three reference strains of H. pylori were studied. Two different varieties of garlic were used. The concentration of AGE required to inhibit the bacterial growth was between 2–5 mg ml⁻¹. The concentration, for both AGE types, to inhibit 90% (MIC₉₀) of isolates was 5 mg ml⁻¹. The minimum bactericidal concentration (MBC) was usually equal to, or two-fold higher than, minimum inhibitory concentration (MIC). Heat treatment of extracts reduced the inhibitory or bactericidal activity against H. pylori ; the boiled garlic extract showed a loss of efficacy from two-to four-fold the values of MIC and the MBC obtained with fresh AGR. The antibacterial activity of garlic was also studied after combination with a proton pump-inhibitor (omeprazole) in a ratio of 250:1. A synergistic effect was found in 47% of strains studied; an antagonistic effect was not observed.     

Cassia alata and the preclinical search for therapeutic agents for the treatment of opportunistic infections in AIDS patients.

In our search for therapeutic agents from natural sources with potential for the treatment of opportunistic infections in patients afflicted with acquired immunodeficiency syndrome (AIDS), we investigated antibacterial and antifungal activities of water extracts of Cassia alata (C. alata). The extracts are traditionally used in Ivory Coast, West Africa to treat bacterial infections caused by Escherichia coli (E. coli), and fungal infections caused by Candida albicans (C. albicans) and dermatophytes. Our working hypothesis was that the extract contains active ingredient(s) which can be isolated, identified and developed into useful antibacterial/antifungal agents for the treatment of opportunistic infections in patients with AIDS. We used the broth dilution and agar dilution methods. Specifically, we focused on E. coli and C. albicans and the effectiveness of the extracts was evaluated relative to those of standard antibacterial agent chloramphenicol and antifungal agent amphotericin B. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) for the water extract of C. alata against E. coli were 1.6 mg/ml and 60 mg/ml, respectively; corresponding data for chloramphenicol were 2 micrograms/ml and 10 micrograms/ml. Similarly, the MIC and minimum fungicidal concentration (MFC) for the extract against C. albicans were 0.39 mg/ml and 60 mg/ml in contrast to 0.58 micrograms/ml and 0.98 micrograms/ml for amphotericin B. From the dose-response curve plots, the extract had an IC50 of 31 mg/ml for E. coli and 28 mg/ml for C. albicans. The data suggest that C. alata extracts contain agent(s) which have therapeutic potential and might be useful if isolated and developed for the treatment of opportunistic infections of AIDS patients.     

Antibacterial potential of Malaysian ethnomedicinal plants against methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA)

This study aimed to evaluate the antibacterial activities of 61 plant extracts from 49 Malaysian ethnomedicinal plants and to investigate the interaction of the active plant extracts in combination with synthetic antibiotics against the MSSA and MRSA strains. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the plant extracts were determined using a microdilution method against MSSA and MRSA strains. The interaction between active plant extracts and the antibiotics was assessed using the checkerboard method. The total fractional inhibitory concentration (∑FIC) indices from the combination were calculated to determine the nature of the interaction. Out of the 61 plant extracts tested against the MSSA strain, 7 plant extracts (̴ 11%) showed MIC values of less than 200 μg/mL, 17 extracts (̴ 28%) showed MIC between 200 and 800 µg/mL and seed extracts of Areca catechu showed MBC values of 400 μg/mL. The seed extract of A. catechu showed MIC and MBC of 400 μg/mL against the MRSA strains while leaf extract of Cocos nucifera showed MIC of 400 μg/mL against MRSA NCTC 12493. When the active plant extracts (MIC ≤ 200 µg/mL for MSSA, and ≤ 400 µg/mL for MRSA) were tested in combination with vancomycin and ciprofloxacin, they showed no interaction against both MSSA and MRSA with ∑FIC between 1.06 and 2.03. These findings provide a preliminary overview of the anti-MSSA and anti-MRSA properties of Malaysian ethnobotanical plants to combat Staphylococcal infections. Further research is needed to establish an antibacterial profile of the tested plant extracts.     

Cassia alata and the preclinical search for therapeutic agents for the treatment of opportunistic infections in AIDS patients.

In our search for therapeutic agents from natural sources with potential for the treatment of opportunistic infections in patients afflicted with acquired immunodeficiency syndrome (AIDS), we investigated antibacterial and antifungal activities of water extracts of Cassia alata (C. alata). The extracts are traditionally used in Ivory Coast, West Africa to treat bacterial infections caused by Escherichia coli (E. coli), and fungal infections caused by Candida albicans (C. albicans) and dermatophytes. Our working hypothesis was that the extract contains active ingredient(s) which can be isolated, identified and developed into useful antimicrobial/antifungal agents for the treatment of opportunistic infections in patients with AIDS. We used the broth dilution and agar dilution methods. Specifically, we focused on E. coli and C. albicans and the effectiveness of the extracts was evaluated relative to those of standard antibacterial agent chloramphenicol and antifungal agent amphotericin B. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) for the water extract of C. alata against E. coli were 1.6 mg/ml and 60 mg/ml respectively; corresponding data for chloramphenicol were 2 ug/ml. Similarly, the MIC and minimum fungicidal concentration (MFC) for the extract against C. albicans were 0.39 mg/ml and 60 mg/ml in contrast to 0.58 ug/ml and 0.98 ug/ml for amphotericin B. From the dose-response curve plots, the extract had an IC50 of 31 mg/ml for E. coli and 28 mg/ml for C. albicans. The data suggest that C. alata extracts contain agent(s) which have therapeutic potential and might be useful if isolated and developed for the treatment of opportunistic infections of AIDS patients.     

抗菌肽对种植体周围炎主要致病菌生长抑制作用的研究

目的研究抗菌肽KSL及其衍生物KSL—W对种植体周围炎主要致病菌的体外抑菌效果。方法应用二倍稀释法检测KSL和KSL—W对血链球菌、具梭核杆菌和牙龈卟啉单胞菌的最小抑菌浓度（MIC）和最小杀菌浓度（MBC）;MTT法检测KSL和KSL—W对成骨样细胞MG-63的细胞毒性。结果KSL和KSL—W对具梭核杆菌的MIC和MBC分别为0．0156mg／mL和0．0313mg／mL,对牙龈卟啉单胞菌的MIC和MBC分别为0．125mg／mL和0．5mg／mL,在0．5mg／mL的浓度范围内对血链球菌没有抑制作用;KSL和KSL-W在0．5mg／mL的浓度范围内没有细胞毒性。结论KSL和KSL—W没有细胞毒性,对具梭核杆菌和牙龈卟啉单胞菌具有抑制作用。     

In vitro antibacterial activity of Psidium guajava Linn. leaf extract on clinical isolates of multidrug resistant Staphylococcus aureus

In the present study, antibacterial activity of aqueous and organic extracts of Psidium guajava leaves was evaluated against multidrug resistant (MDR) clinical isolates of Staphylococcus aureus strains collected from hospitals in northern (Malabar region) Kerala. The strains which exhibited resistance against all the antibiotics tested was selected for antibacterial assays. Minimum inhibitory concentration (MIC) for methanolic and aqueous extracts was found to be 625 ug/ml and 7.5 mg/ml, respectively. Minimum bactericidal concentration (MBC) recorded for methanolic and aqueous extracts was 1.25 and 12.5 mg/ml, respectively. Methanolic extract at minimum bactericidal concentration inhibited the growth of MDR strain by 80%. Time-kill assay revealed that methanolic extract (4 mg/ml) killed MDR bacteria within 10 hr. Total polypeptide profiling of bacterial cultures by SDS-PAGE indicated a high degree of protein degradative activity of the extract. Finally, a human RBC based haemolytic assay showed absence of haemolysis even at concentrations higher than that of MBC, advocating thereby its safety in therapeutic use.